On Monday, data revealed that the inflation rate in India cooled more in August. That will add pressure on the Reserve Bank of India to cut the interest rates once more which could be on the cards as soon as the current month, in order to boost economic growth.

The price pressure at their record low levels is building expectations that the country's central bank will cut the borrowing costs by a minimum of 25 basis points when it reviews its policy next on September 29. There have already been three cuts in the rates this year.

Renewable Energy tops the list of the agenda for the NDA government. Earlier the MNRE or the Ministry of New and Renewable Energy in New Delhi which was considered as a step-down posting by the bureaucrats no more is considered as a less visible ministry.

The government has made it a primary focus in an effort to make India less dependent on power fuelled by coal.

On Monday, Narendra Modi, the Prime Minister of India and the U. S. President Barack Obama vowed to develop and intensify the strategic partnership between their countries and set it as a model for the entire world.

Gap Inc. the mega-retailer from San Francisco is planning to tap the Indian market and cash in on the purchasing power of the country's 1.2 billion people with an introduction of forty franchised stores which are scheduled to open in the coming year.

Gap said that it is working closely with Arvind Lifestyle Brand Ltd. for opening of its store to open stores in the world's second most populated country.

Narendra Modi the Indian Prime Minister during their meeting on Friday restate to John Kerry the US Secretary of State in absolutely clear terms that his responsibility for India's food security is as important as the keenness of the West to witness the passing of the Trade Facilitation Protocol.

Conceding that the Center for Science and Environment's (CSE) discoveries about chicken being bolstered on anti-infection agents were "disturbing' additionally something that open health experts have since quite a while ago suspected, the Indian Medical Association on Thursday requested a prompt clip down on the abuse of anti-toxins.

India's pharmaceutical misfortunes proceed, as the US Food and Drug Administration (FDA) reported this week that it was reviewing 200 vials of items created by Sun Pharmaceuticals Industries Ltd.

The news was advertised by means of an implementation report posted on the FDA's official site, in which it states that 200 vials of a chemotherapy drug known as gemcitabine are, no doubt pulled from US shelves quickly.